申请人:THE UPJOHN COMPANY
公开号:EP0153858A2
公开(公告)日:1985-09-04
The use of a PGE-like prostaglandin for the manufacture of a medicament for the treatment or prevention of a human suffering from or prone to acute respiratory distress syndrome or multiple vital organ damage, and for the treatment of a human suffering from shock, trauma, sepsis or any combination thereof.
使用 PGE 类前列腺素制造治疗或预防急性呼吸窘迫综合征或多重要器官损伤的药物,以及治疗休克、创伤、败血症或其任何组合的药物。